H13018—Dermatology

Contact:

Mentor/Principal Investigator: Santosh K. Katiyar, Ph.D. Professor Department of Dermatology  Mailing address: VH 557 1530 3RD AVENUE S BIRMINGHAM AL 35294-0019  Tel: (205) 975-2608 Fax: (205) 975-5745 E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.


Postdoctoral Positions Available

Job Description: The accomplishment of the project work related to "Chemoprevention of cancer by naturally occurring botanical supplements or antioxidants" using cell culture and animal models. This will include the investigation of the causes, mechanisms and preventive approaches for cancer. This work will require experience in cell culture, animal handling, plus basic biochemistry/chemistry and molecular biology techniques such as Western, Northern, RT/PCR techniques and immunohistochemistry. Responsibilities will include design and execution of experimental procedures, the maintenance of complete laboratory records of experiements, the preparation of manuscripts suitable for publication and presentations at internal and external venues as required.

Position Requirements: Applicants should have experience in carcinogenesis, their causes, mechanisms and chemopreventive approaches. In addition to experience the researchers should have interest and a clear vision of future progress in cancer mechanisms and their prevention.

Applicants should send curriculum vitae with a description of research interests and names of three references with email addresses to: Santosh K. Katiyar, Ph.D., This email address is being protected from spambots. You need JavaScript enabled to view it. .

UAB News

  • As kids prepare to head back to school, required immunizations are typically on the to-do list, but getting potentially lifesaving vaccines should not end when adulthood begins, says one University of Alabama at Birmingham infectious diseases expert.

  • effrey R. Curtis, M.D., from the University of Alabama at Birmingham, and colleagues utilized 1998 to 2011 data from the U.S. Veterans Health Administration to identify RA patients initiating rituximab, abatacept, or anti-tumor necrosis factor (anti-TNF) therapy. The authors sought to assess the comparative risk of hospitalized infection associated with anti-TNF and non-anti-TNF biologic agents.

UAB Research News

  • New drugs to slow or even prevent Parkinson’s could be in human studies as early as 2015.Written by Matt Windsor An enzyme closely associated with genetic forms of Parkinson’s disease appears to play a larger role in its progression than previously thought, say investigators at the University of Alabama at Birmingham. The new research offers encouraging evidence that drugs to block this enzyme, known as leucine-rich repeat kinase 2 or LRRK2, could slow — or even...

  • UAB School of Nursing's federally funded study shows both the patient and caregiver benefit from early palliative care.The earlier a specific phone-based, palliative care support program can be introduced to caregivers, the better they will be able to cope with the caregiving experience, according to research conducted by University of Alabama at Birmingham School of Nursing investigators. The patient outcomes from the study, known as ENABLE III, were presented June 3 at the American Society of...